Form 8-K - Current report:
SEC Accession No. 0001193125-25-080728
Filing Date
2025-04-15
Accepted
2025-04-15 07:38:43
Documents
15
Period of Report
2025-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d923035d8k.htm   iXBRL 8-K 57176
2 EX-99.1 d923035dex991.htm EX-99.1 8764
6 GRAPHIC g923035page7.jpg GRAPHIC 2954
  Complete submission text file 0001193125-25-080728.txt   202463

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20250414.xsd EX-101.SCH 2520
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20250414_lab.xml EX-101.LAB 17912
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20250414_pre.xml EX-101.PRE 11230
17 EXTRACTED XBRL INSTANCE DOCUMENT d923035d8k_htm.xml XML 3711
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 25837581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)